• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Nucleosome assembly protein 1-like 5 (NAP1L5)

ACP19278

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19278 Target NameNAP1L5
Target Synonyms1110020M21Rik; down regulated in liver malignancy; DRLM; NAP1L5; NP1L5_HUMAN; Nucleosome assembly protein 1-like 5FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-182
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96NT1
Background Information
  • Uniprot Id

    Q96NT1

  • Target Species

    Human

  • Target Name

    NAP1L5

  • Target Full Name

    Nucleosome assembly protein 1-like 5

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    Nucleosome assembly protein (NAP) family

  • Target Tissue Specificity

    Predominantly expressed in brain.

  • Target Synonyms

    1110020M21Rik; down regulated in liver malignancy; DRLM; NAP1L5; NP1L5_HUMAN; Nucleosome assembly protein 1-like 5

  • Target Background

    This gene encodes a protein that shares sequence similarity to nucleosome assembly factors, but may be localized to the cytoplasm rather than the nucleus. Expression of this gene is downregulated in hepatocellular carcinomas. This gene is located within a differentially methylated region (DMR) and is imprinted and paternally expressed. There is a related pseudogene on chromosome 4.

Inquire Recombinant Human Nucleosome assembly protein 1-like 5 (NAP1L5) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification